ALLIANCEBERNSTEIN L.P. - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 123 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,157,823
-96.9%
57,718
-95.6%
0.00%
-100.0%
Q2 2023$37,277,681
+68.0%
1,321,435
+2.4%
0.02%
+50.0%
Q1 2023$22,193,091
-19.3%
1,290,296
-5.5%
0.01%
-16.7%
Q4 2022$27,501,130
-4.7%
1,365,498
+2.5%
0.01%
-14.3%
Q3 2022$28,849,000
-24.2%
1,331,884
-1.7%
0.01%
-17.6%
Q2 2022$38,060,000
-17.2%
1,354,463
+35.9%
0.02%
-5.6%
Q1 2022$45,990,000
-41.0%
996,759
+7.5%
0.02%
-35.7%
Q4 2021$77,918,000
+18.6%
926,937
-6.0%
0.03%
+7.7%
Q3 2021$65,704,000
+31.3%
985,953
+4.8%
0.03%
+30.0%
Q2 2021$50,052,000
+4.4%
940,828
-14.9%
0.02%
-4.8%
Q1 2021$47,958,000
+10.7%
1,105,282
+32.5%
0.02%
+5.0%
Q4 2020$43,341,000
+72.0%
834,448
+8.3%
0.02%
+42.9%
Q3 2020$25,196,000
+5.3%
770,770
+54.7%
0.01%0.0%
Q2 2020$23,927,000498,2720.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 1,824,583$39,520,00014.33%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,301,771$49,857,0004.79%
Matrix Capital Management Company, LP 9,199,973$199,271,0003.81%
Integral Health Asset Management, LLC 550,000$11,913,0002.31%
Avidity Partners Management LP 4,223,100$91,472,0001.86%
Affinity Asset Advisors, LLC 170,000$3,682,0001.03%
Eventide Asset Management 1,861,000$40,309,0000.79%
Sofinnova Investments, Inc. 583,357$12,636,0000.74%
Nicholas Investment Partners, LP 158,704$3,438,0000.32%
SECTORAL ASSET MANAGEMENT INC 60,000$1,300,0000.26%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders